Back

Hepatocyte growth factor has prognostic utility in light chain and transthyretin cardiac amyloidosis

1 September 2019 (09:51 - 10:00)
Organised by:
Congress Presentation Part of: Hot topics in myocardial and pericardial diseases Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Jennifer Miao

Vanderbilt University Medical Center, Nashville (United States of America)

8 More presentations in this session

Presentation thumbnail
Role of 18FDG(fluorodeoxyglucose)-PET (positron emission tomography) for differential diagnosis of pericardial disease
Doctor C. Hyeon (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Interim analysis of data from a long-term, extension trial of tafamidis meglumine in patients with transthyretin amyloid cardiomyopathy
Doctor S. Gottlieb (Baltimore, US)
Abstract Slides Video
Presentation thumbnail
Tafamidis versus liver transplantation as first-line therapy for hereditary transthyretin amyloidosis
Doctor V. Algalarrondo (Paris, FR)
Abstract
Presentation thumbnail
Myocardial perfusion mapping in cardiac amyloidosis- exploring the spectrum from infiltration to ischaemia
Doctor T. Kotecha (London, GB)
Abstract Slides Video
Presentation thumbnail
The increased serum level of troponin T after immunosuppression therapy reflects sustained myocardial FDG accumulation in cardiac sarcoidosis
Doctor R. Morimoto (Nagoya, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Hot topics in myocardial and pericardial diseases

The Event

Event poster

ESC Congress 2019

1 September 2019 09:51 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic value of cardiac biomarkers in patients with transthyretin deposition cardiac amyloidosis.
29 June 2021
thumbnail
Congress Presentation
Hepatocyte Growth Factor as a new marker of pulmonary hypertension in heart failure patients.
29 June 2021
thumbnail
Congress Presentation
Quantitative and functional evaluation of endothelial progenitor cells in patients with cardiac amyloidosis
31 August 2020
thumbnail
Congress Session
Cardiac amyloidosis and heart failure
20 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources